{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T12:17:36Z","timestamp":1772281056385,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T00:00:00Z","timestamp":1710374400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T00:00:00Z","timestamp":1710374400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1038\/s41440-024-01629-3","type":"journal-article","created":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T10:06:43Z","timestamp":1710410803000},"page":"1298-1308","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Donepezil attenuates progression of cardiovascular remodeling and improves prognosis in spontaneously hypertensive rats with chronic myocardial infarction"],"prefix":"10.1038","volume":"47","author":[{"given":"Meihua","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Can","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Kawada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunori","family":"Uemura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shohei","family":"Yokota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Matsushita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keita","family":"Saku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,3,14]]},"reference":[{"key":"1629_CR1","doi-asserted-by":"publisher","unstructured":"Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Jr Colvin MM, et al. 2017 ACC\/AHA\/HFSA Focused Update of the 2013 ACCF\/AHA Guideline for the Management of Heart Failure: A report of the American college of cardiology\/american heart association task force on clinical practice guidelines and the heart failure society of America. J Card Fail. 2017. https:\/\/doi.org\/10.1016\/j.cardfail.2017.04.014.","DOI":"10.1016\/j.cardfail.2017.04.014"},{"key":"1629_CR2","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1002\/ejhf.592","volume":"18","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2016;18:891\u2013975.","journal-title":"Eur J Heart Fail"},{"key":"1629_CR3","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1161\/CIRCRESAHA.116.303603","volume":"116","author":"S Oparil","year":"2015","unstructured":"Oparil S, Schmieder RE. New approaches in the treatment of hypertension. Circ Res. 2015;116:1074\u201395.","journal-title":"Circ Res"},{"key":"1629_CR4","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1136\/heart.89.8.854","volume":"89","author":"AS Androne","year":"2003","unstructured":"Androne AS, Hryniewicz K, Goldsmith R, Arwady A, Katz SD. Acetylcholinesterase inhibition with pyridostigmine improves heart rate recovery after maximal exercise in patients with chronic heart failure. Heart. 2003;89:854\u20138.","journal-title":"Heart"},{"key":"1629_CR5","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/S0140-6736(97)11144-8","volume":"351","author":"MT La Rovere","year":"1998","unstructured":"La Rovere MT, Bigger JT Jr, Marcus FI, Mortara A, Schwartz PJ. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators. Lancet. 1998;351:478\u201384.","journal-title":"Lancet"},{"key":"1629_CR6","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/0735-1097(92)90167-L","volume":"20","author":"M Packer","year":"1992","unstructured":"Packer M. The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure. J Am Coll Cardiol. 1992;20:248\u201354.","journal-title":"J Am Coll Cardiol"},{"key":"1629_CR7","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/S0733-8651(05)70223-X","volume":"19","author":"ET Rosenwinkel","year":"2001","unstructured":"Rosenwinkel ET, Bloomfield DM, Arwady MA, Goldsmith RL. Exercise and autonomic function in health and cardiovascular disease. Cardiol Clin. 2001;19:369\u201387.","journal-title":"Cardiol Clin"},{"key":"1629_CR8","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/0735-1097(91)90602-6","volume":"18","author":"PF Binkley","year":"1991","unstructured":"Binkley PF, Nunziata E, Haas GJ, Nelson SD, Cody RJ. Parasympathetic withdrawal is an integral component of autonomic imbalance in congestive heart failure: demonstration in human subjects and verification in a paced canine model of ventricular failure. J Am Coll Cardiol. 1991;18:464\u201372.","journal-title":"J Am Coll Cardiol"},{"key":"1629_CR9","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"TA McDonagh","year":"2021","unstructured":"McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Bohm M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42:3599\u2013726.","journal-title":"Eur Heart J"},{"key":"1629_CR10","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/0002-9149(87)90795-8","volume":"59","author":"RE Kleiger","year":"1987","unstructured":"Kleiger RE, Miller JP, Bigger JT Jr, Moss AJ. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol. 1987;59:256\u201362.","journal-title":"Am J Cardiol"},{"key":"1629_CR11","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/0002-9149(91)90774-F","volume":"68","author":"O Odemuyiwa","year":"1991","unstructured":"Odemuyiwa O, Malik M, Farrell T, Bashir Y, Poloniecki J, Camm J. Comparison of the predictive characteristics of heart rate variability index and left ventricular ejection fraction for all-cause mortality, arrhythmic events and sudden death after acute myocardial infarction. Am J Cardiol. 1991;68:434\u20139.","journal-title":"Am J Cardiol"},{"key":"1629_CR12","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1161\/01.CIR.0000105721.71640.DA","volume":"109","author":"M Li","year":"2004","unstructured":"Li M, Zheng C, Sato T, Kawada T, Sugimachi M, Sunagawa K. Vagal nerve stimulation markedly improves long-term survival after chronic heart failure in rats. Circulation. 2004;109:120\u20134.","journal-title":"Circulation"},{"key":"1629_CR13","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1093\/eurheartj\/ehq391","volume":"32","author":"GM De Ferrari","year":"2011","unstructured":"De Ferrari GM, Crijns HJ, Borggrefe M, Milasinovic G, Smid J, Zabel M, et al. Chronic vagus nerve stimulation: a new and promising therapeutic approach for chronic heart failure. Eur Heart J. 2011;32:847\u201355.","journal-title":"Eur Heart J"},{"key":"1629_CR14","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.cardfail.2014.08.009","volume":"20","author":"RK Premchand","year":"2014","unstructured":"Premchand RK, Sharma K, Mittal S, Monteiro R, Dixit S, Libbus I, et al. Autonomic regulation therapy via left or right cervical vagus nerve stimulation in patients with chronic heart failure: results of the ANTHEM-HF trial. J Card Fail. 2014;20:808\u201316.","journal-title":"J Card Fail"},{"key":"1629_CR15","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jacc.2016.03.525","volume":"68","author":"MR Gold","year":"2016","unstructured":"Gold MR, Van Veldhuisen DJ, Hauptman PJ, Borggrefe M, Kubo SH, Lieberman RA. et al. Vagus nerve stimulation for the treatment of heart failure: the INOVATE-HF trial. J Am Coll Cardiol. 2016;68:149\u201358.","journal-title":"J Am Coll Cardiol"},{"key":"1629_CR16","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1253\/circj.CJ-13-0476","volume":"77","author":"M Li","year":"2013","unstructured":"Li M, Zheng C, Kawada T, Inagaki M, Uemura K, Shishido T, et al. Donepezil markedly improves long-term survival in rats with chronic heart failure after extensive myocardial infarction. Circ J. 2013;77:2519\u201325.","journal-title":"Circ J"},{"key":"1629_CR17","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1002\/ejhf.164","volume":"16","author":"M Li","year":"2014","unstructured":"Li M, Zheng C, Kawada T, Inagaki M, Uemura K, Sugimachi M. Adding the acetylcholinesterase inhibitor, donepezil, to losartan treatment markedly improves long-term survival in rats with chronic heart failure. Eur J Heart Fail. 2014;16:1056\u201365.","journal-title":"Eur J Heart Fail"},{"key":"1629_CR18","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12576-020-00739-0","volume":"70","author":"M Li","year":"2020","unstructured":"Li M, Zheng C, Kawada T, Inagaki M, Uemura K, Sugimachi M. Intracerebroventricular infusion of donepezil prevents cardiac remodeling and improves the prognosis of chronic heart failure rats. J Physiol Sci. 2020;70:11.","journal-title":"J Physiol Sci"},{"key":"1629_CR19","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s10557-020-07062-1","volume":"35","author":"M Li","year":"2021","unstructured":"Li M, Zheng C, Kawada T, Inagaki M, Uemura K, Akiyama T, et al. Impact of peripheral \u03b17-nicotinic acetylcholine receptors on cardioprotective effects of donepezil in chronic heart failure rats. Cardiovasc Drugs Ther. 2021;35:877\u201388.","journal-title":"Cardiovasc Drugs Ther"},{"key":"1629_CR20","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1002\/ejhf.319","volume":"17","author":"H Shimokawa","year":"2015","unstructured":"Shimokawa H, Miura M, Nochioka K, Sakata Y. Heart failure as a general pandemic in Asia. Eur J Heart Fail. 2015;17:884\u201392.","journal-title":"Eur J Heart Fail"},{"key":"1629_CR21","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1093\/ajh\/hpaa195","volume":"34","author":"JD Humphrey","year":"2021","unstructured":"Humphrey JD. Mechanisms of vascular remodeling in hypertension. Am J Hypertens. 2021;34:432\u201341.","journal-title":"Am J Hypertens"},{"key":"1629_CR22","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1258\/002367704322968812","volume":"38","author":"G Itter","year":"2004","unstructured":"Itter G, Jung W, Juretschke P, Schoelkens BA, Linz W. A model of chronic heart failure in spontaneous hypertensive rats (SHR). Lab Anim. 2004;38:138\u201348.","journal-title":"Lab Anim"},{"key":"1629_CR23","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1161\/ATVBAHA.118.311229","volume":"38","author":"IAM Brown","year":"2018","unstructured":"Brown IAM, Diederich L, Good ME, DeLalio LJ, Murphy SA, Cortese-Krott MM, et al. Vascular smooth muscle remodeling in conductive and resistance arteries in hypertension. Arterioscler Thromb Vasc Biol. 2018;38:1969\u201385.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1629_CR24","doi-asserted-by":"publisher","first-page":"4360","DOI":"10.3390\/jcm10194360","volume":"10","author":"I Avitan","year":"2021","unstructured":"Avitan I, Halperin Y, Saha T, Bloch N, Atrahimovich D, Polis B, et al. Towards a consensus on Alzheimer\u2019s disease comorbidity? J Clin Med. 2021;10:4360.","journal-title":"J Clin Med"},{"key":"1629_CR25","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.1093\/eurheartj\/eht182","volume":"34","author":"P Nordstrom","year":"2013","unstructured":"Nordstrom P, Religa D, Wimo A, Winblad B, Eriksdotter M. The use of cholinesterase inhibitors and the risk of myocardial infarction and death: a nationwide cohort study in subjects with Alzheimer\u2019s disease. Eur Heart J. 2013;34:2585\u201391.","journal-title":"Eur Heart J"},{"key":"1629_CR26","doi-asserted-by":"publisher","first-page":"831730","DOI":"10.3389\/fcvm.2022.831730","volume":"9","author":"MJ Hsieh","year":"2022","unstructured":"Hsieh MJ, Chen DY, Lee CH, Wu CL, Chen YJ, Huang YT, et al. Association between cholinesterase inhibitors and new-onset heart failure in patients with Alzheimer\u2019s disease: a nationwide propensity score matching study. Front Cardiovasc Med. 2022;9:831730.","journal-title":"Front Cardiovasc Med"},{"key":"1629_CR27","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3233\/JAD-201551","volume":"81","author":"R Morris","year":"2021","unstructured":"Morris R, Luboff H, Jose RP, Eckhoff K, Bu K, Pham M, et al. Bradycardia due to donepezil in adults: systematic analysis of FDA adverse event reporting system. J Alzheimers Dis. 2021;81:297\u2013307.","journal-title":"J Alzheimers Dis"},{"key":"1629_CR28","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1093\/eurheartj\/ehx391","volume":"38","author":"H Baumgartner","year":"2017","unstructured":"Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ, et al. 2017 ESC\/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2017;38:2739\u201391.","journal-title":"Eur Heart J"},{"key":"1629_CR29","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12576-022-00836-2","volume":"72","author":"M Li","year":"2022","unstructured":"Li M, Zheng C, Kawada T, Uemura K, Inagaki M, Saku K, et al. Early donepezil monotherapy or combination with metoprolol significantly prevents subsequent chronic heart failure in rats with reperfused myocardial infarction. J Physiol Sci. 2022;72:12.","journal-title":"J Physiol Sci"},{"key":"1629_CR30","doi-asserted-by":"publisher","first-page":"C13","DOI":"10.1093\/eurheartj\/sul009","volume":"8","author":"B Silke","year":"2006","unstructured":"Silke B. Beta-blockade in CHF: pathophysiological considerations. Eur Heart J. 2006;8:C13\u20138.","journal-title":"Eur Heart J"},{"key":"1629_CR31","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1161\/CIRCULATIONAHA.117.027451","volume":"137","author":"D da Silva Goncalves Bos","year":"2018","unstructured":"da Silva Goncalves Bos D, Van Der Bruggen CEE, Kurakula K, Sun XQ, Casali KR, Casali AG, et al. Contribution of impaired parasympathetic activity to right ventricular dysfunction and pulmonary vascular remodeling in pulmonary arterial hypertension. Circulation. 2018;137:910\u201324.","journal-title":"Circulation"},{"key":"1629_CR32","first-page":"H289","volume":"257","author":"A DeFelice","year":"1989","unstructured":"DeFelice A, Frering R, Horan P. Time course of hemodynamic changes in ras with healed severe myocardial infarction. Am J Physiol. 1989;257:H289\u201396.","journal-title":"Am J Physiol"},{"key":"1629_CR33","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1111\/1440-1681.12607","volume":"43","author":"JP Collister","year":"2016","unstructured":"Collister JP, Hartnett C, Mayerhofer T, Nahey D, Stauthammer C, Kr\u00fcger M, et al. Overexpression of copper\/zinc superoxide dismutase in the median preoptic nucleus improves cardiac function after myocardial infarction in the rat. Clin Exp Pharm Physiol. 2016;43:960\u20136.","journal-title":"Clin Exp Pharm Physiol"},{"key":"1629_CR34","first-page":"9858","volume":"10","author":"Y Miao","year":"2017","unstructured":"Miao Y, Li M, Wang C, Li H, Chen H. Effect of \u03b2-adrenergic receptor kinase inhibitor on post-myocardial infarction heart failure in rats. Int J Clin Exp Pathol. 2017;10:9858\u201365.","journal-title":"Int J Clin Exp Pathol"},{"key":"1629_CR35","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/0002-8703(86)90563-6","volume":"111","author":"PJ Fletcher","year":"1986","unstructured":"Fletcher PJ, Pfeffer JM, Pfeffer MA. Altered sensitivity to increases in vascular resistance in rats with hypertension and myocardial infarction. Am Heart J. 1986;111:120.","journal-title":"Am Heart J"},{"key":"1629_CR36","doi-asserted-by":"publisher","first-page":"F1105","DOI":"10.1152\/ajprenal.00194.2006","volume":"292","author":"WA Cupples","year":"2007","unstructured":"Cupples WA, Braam B. Assessment of renal autoregulation. Am J Physiol Ren Physiol. 2007;292:F1105\u201323.","journal-title":"Am J Physiol Ren Physiol"},{"key":"1629_CR37","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1084\/jem.20120571","volume":"209","author":"U Andersson","year":"2012","unstructured":"Andersson U, Tracey KJ. Neural reflexes in inflammation and immunity. J Exp Med. 2012;209:1057\u201368.","journal-title":"J Exp Med"},{"key":"1629_CR38","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/nature01339","volume":"421","author":"H Wang","year":"2003","unstructured":"Wang H, Yu M, Ochani M, Amella CA, Tanovic M, Susarla S, et al. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature. 2003;421:384\u20138.","journal-title":"Nature"},{"key":"1629_CR39","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.vph.2014.03.006","volume":"61","author":"T Hashimoto","year":"2014","unstructured":"Hashimoto T, Ichiki T, Watanabe A, Hurt-Camejo E, Michaelsson E, Ikeda J, et al. Stimulation of alpha7 nicotinic acetylcholine receptor by AR-R17779 suppresses atherosclerosis and aortic aneurysm formation in apolipoprotein E-deficient mice. Vasc Pharm. 2014;61:49\u201355.","journal-title":"Vasc Pharm"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41440-024-01629-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-024-01629-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-024-01629-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T07:04:54Z","timestamp":1716275094000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41440-024-01629-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,14]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["1629"],"URL":"https:\/\/doi.org\/10.1038\/s41440-024-01629-3","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,14]]},"assertion":[{"value":"6 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Animal care protocols and all experiments were performed in strict accordance with the Guiding Principles for the Care and Use of Animals in the Field of Physiological Science, which was approved by the Physiological Society of Japan. All protocols were reviewed and approved by the Animal Subject Committee of the National Cerebral and Cardiovascular Center (#15004 and #16002).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study did not involve human participants. The Animal Subject Committee of the National Cerebral and Cardiovascular Center has approved the animal experiments.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}}]}}